 Miltefosine is also produced by Profounda, a private pharmaceutical company.It is active against some bacteria and fungi, as well as human trematode "Schistosoma mansoni" and the snail that spreads it "Biomphalaria alexandrina".Miltefosine is being investigated by researchers interested in finding treatments for infections which have become resistant to existing drugs.